As part of its efforts to capture patients’ perspectives, the U.S. FDA is considering establishing an “Office of Patient Affairs” that would be tasked with coordinating patient engagement across the agency. The move to create the office would be part of the agency’s efforts to offer a single entry point to the Agency for the patient community and patient stakeholders.¬† (Regulatory Focus)